Join us for a virtual KOL webinar featuring Dr. Cheerag Shirodaria (Oxford University Hospitals), Dr. Marc Bonaca (University of Colorado…
Join DiaMedica Therapeutics for a virtual key opinion leader (KOL) event featuring Prof. Catherine Cluver, MD, PhD (Stellenbosch University), Prof. Stephen…
Join Cognition Therapeutics for an investor webcast to discuss the clinical efficacy, safety and biomarker findings from the Phase 2…
Join Arcutis Biotherapeutics for a virtual Key Opinion Leader (KOL) event featuring a leading dermatology and immune-mediated skin disease expert…
Join Skye Bioscience for a virtual KOL Event featuring Louis J. Aronne, MD, FACP (Weill Cornell Medicine), Marcus DaSilva Goncalves, MD,…
Phase 2b RewinD-LB trial of neflamapimod for the treatment of dementia with Lewy Bodies (DLB) is fully enrolled with topline…
The Abliva team invites you to a conference call to discuss the positive outcome of the interim analysis for FALCON,…
Join Aligos Therapeutics for a virtual KOL event featuring Mark Sulkowski, MD (Johns Hopkins University School of Medicine), who will…
Join Biora Therapeutics for a virtual KOL event featuring Bruce Sands, MD, MS (Icahn School of Medicine at Mount Sinai) and Brian Feagan,…
Join Arrowhead Pharmaceuticals for Part III of its 2024 Summer Series of R&D Webinars, featuring Matthias A. Salathe, MD (University of…
Join Purple Biotech for a virtual key opinion leader (KOL) event featuring Michael Cecchini, MD (Yale School of Medicine) and E. Gabriela Chiorean,…
Join IDEAYA Biosciences for an investor webcast to provide a clinical data update for the IDE397 Phase 2 monotherapy expansion…

Nusano and LifeSci Advisors invite you to go back to school . . . Join us on Friday, June 28,…
Join R1 RCM, a leading provider of technology-driven solutions that transform the financial performance and patient experience for health systems,…
Join X4 Pharmaceuticals for a virtual investor event featuring Peter E. Newburger, MD (UMass Chan Medical School) and Jean Donadieu, MD, PhD (Trousseau…
Join FibroGen for the second part of the virtual KOL investor event series featuring Rahul Aggarwal, MD (University of California San Francisco),…